The case for Novo Nordisk. Right now Novo Nordisk has a considerable lead on Lilly in GLP-1 market share, and a couple of ...

In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and ...

Allowing Medicare to cover popular weight loss drugs such as Wegovy and Zepbound could increase federal spending by billions ...

France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.View on ...

Weight loss drugs such as Wegovy have risen in popularity in recent months - but how exactly does it work and what are the side effects?

Novo Nordisk, the pharmaceutical company behind the world’s most popular weight-loss injections, is expanding its global ...

This article delves into the pros and cons of these drugs, addressing potential side effects (including the rare ones).

As with any new drug, parents and doctors may worry that the use of GLP-1 weight-loss meds by children and teens might ...

“ (Weight loss medications) can help, for sure, but exercise and getting enough protein to make sure you aren’t losing muscle ...

Medicare covers Wegovy as a treatment to reduce the risk of serious cardiovascular events in people who have overweight or obesity. It does not cover Wegovy for weight loss.

Weight loss drugs like Ozempic were associated with a lower risk of suicidal thoughts in teens with obesity, a new study found.

Hoping your company will begin paying for anti-obesity medications like Wegovy? You may be in luck. A growing number of ...